MIR4429

Across TCGA pan-cancer cohorts, MIR4429 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated MIR4429 data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher MIR4429 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR4429 expression acts as an unfavorable survival marker, although some lineages such as BRCA and PRAD show a favorable association.

UCS, BLCA, and BRCA are the cancer types where MIR4429 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	OS	Tertile	All	0.102	0.688	<.001	108	view →
BLCA	OS	Tertile	All	0.187	0.720	.002	72	view →
BRCA	DFS	Median	III,IV	0.944	0.816	<.001	57	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	48	view →
GBM	OS	Tertile	All	0.089	0.415	<.001	45	view →
ESCA	OS	Tertile	All	0.198	0.872	.003	36	view →
UCEC	OS	Tertile	IV	0.200	0.515	.047	18	view →
LUAD	OS	Tertile	II,III,IV	0.295	0.595	.026	9	view →
PRAD	DFS	Tertile	All	0.901	0.765	.026	4	view →
LIHC	OS	Tertile	III,IV	0.891	0.555	.048	3	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

MIR4429–UCS (OS)

Open the UCS breakdown →